カテゴリ： QYResearch, 世界, 消費財/食品

麻疹/風疹ワクチンの世界市場2025年：一価ワクチン、多価ワクチン

■ 英語タイトル：Global Measles and Rubella Vaccines Market Research Report 2025

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7494）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7494
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：70
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥417,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥626,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥835,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[麻疹/風疹ワクチンの世界市場2025年：一価ワクチン、多価ワクチン]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は麻疹/風疹ワクチンのグローバル市場について調査・分析し、世界の麻疹/風疹ワクチン市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（一価ワクチン、多価ワクチン）、用途別セグメント分析（病院、クリニック、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Serum Institute of India Ltd.、Merck & Co. Inc.、GlaxoSmithKline Inc.、Takeda Pharmaceutical Companyなどが含まれています。麻疹/風疹ワクチンのグローバル市場は、2024年にXXX米ドル、2031年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。貿易戦争とロシア・ウクライナ戦争の影響は、麻疹/風疹ワクチン市場規模を算出する際に考慮しました。

・麻疹/風疹ワクチン市場の概要
- 製品の定義
- 麻疹/風疹ワクチンの種類別セグメント
- 世界の麻疹/風疹ワクチン市場規模：タイプ別分析（一価ワクチン、多価ワクチン）
- 麻疹/風疹ワクチンの用途別セグメント
- 世界の麻疹/風疹ワクチン市場規模：用途別分析（病院、クリニック、その他）
- 世界の麻疹/風疹ワクチン市場規模予測（2020年-2031年）
- 麻疹/風疹ワクチンの平均価格推移（2020年-2031年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 麻疹/風疹ワクチン市場の競争状況およびトレンド

・麻疹/風疹ワクチンの地域別市場規模
- 北米の麻疹/風疹ワクチン市場規模（2020年-2031年）
- 米国の麻疹/風疹ワクチン市場規模（2020年-2031年）
- ヨーロッパの麻疹/風疹ワクチン市場規模（2020年-2031年）
- アジア太平洋の麻疹/風疹ワクチン市場規模（2020年-2031年）
- 中国の麻疹/風疹ワクチン市場規模（2020年-2031年）
- 日本の麻疹/風疹ワクチン市場規模（2020年-2031年）
- 韓国の麻疹/風疹ワクチン市場規模（2020年-2031年）
- インドの麻疹/風疹ワクチン市場規模（2020年-2031年）
- オーストラリアの麻疹/風疹ワクチン市場規模（2020年-2031年）
- 中南米の麻疹/風疹ワクチン市場規模（2020年-2031年）
- 中東・アフリカの麻疹/風疹ワクチン市場規模（2020年-2031年）

・種類別セグメント：一価ワクチン、多価ワクチン
- 世界の麻疹/風疹ワクチンのタイプ別販売量（2020年-2025年）
- 世界の麻疹/風疹ワクチンのタイプ別売上（2020年-2025年）
- 世界の麻疹/風疹ワクチンのタイプ別価格

・用途別セグメント：病院、クリニック、その他
- 世界の麻疹/風疹ワクチンの用途別販売量（2020年-2025年）
- 世界の麻疹/風疹ワクチンの用途別売上（2020年-2025年）
- 世界の麻疹/風疹ワクチンの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Serum Institute of India Ltd.、Merck & Co. Inc.、GlaxoSmithKline Inc.、Takeda Pharmaceutical Company

・産業チェーンと販売チャネルの分析
- 麻疹/風疹ワクチン産業チェーン分析
- 麻疹/風疹ワクチンの主要原材料
- 麻疹/風疹ワクチンの販売チャネル
- 麻疹/風疹ワクチンのディストリビューター
- 麻疹/風疹ワクチンの主要顧客

・麻疹/風疹ワクチン市場ダイナミクス
- 麻疹/風疹ワクチンの業界動向
- 麻疹/風疹ワクチン市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Measles and Rubella Vaccines market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of % during the forecast period 2025-2031. The influence of trade war and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Measles and Rubella Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Measles and Rubella Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The key global manufacturers of Measles and Rubella Vaccines include Serum Institute of India Ltd., Merck & Co. Inc., GlaxoSmithKline Inc. and Takeda Pharmaceutical Company, etc. in 2024, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Measles and Rubella Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measles and Rubella Vaccines.
The Measles and Rubella Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Measles and Rubella Vaccines market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Measles and Rubella Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Serum Institute of India Ltd.
Merck & Co. Inc.
GlaxoSmithKline Inc.
Takeda Pharmaceutical Company
Segment by Type
Monovalent Vaccines
Multivalent Vaccines
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Measles and Rubella Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Measles and Rubella Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Measles and Rubella Vaccines Market Overview
1.1 Product Overview and Scope of Measles and Rubella Vaccines
1.2 Measles and Rubella Vaccines Segment by Type
1.2.1 Global Measles and Rubella Vaccines Market Value Comparison by Type (2025-2031)
1.2.2 Monovalent Vaccines
1.2.3 Multivalent Vaccines
1.3 Measles and Rubella Vaccines Segment by Application
1.3.1 Global Measles and Rubella Vaccines Market Value by Application: (2025-2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Measles and Rubella Vaccines Market Size Estimates and Forecasts
1.4.1 Global Measles and Rubella Vaccines Revenue 2020-2031
1.4.2 Global Measles and Rubella Vaccines Sales 2020-2031
1.4.3 Global Measles and Rubella Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Measles and Rubella Vaccines Market Competition by Manufacturers
2.1 Global Measles and Rubella Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Measles and Rubella Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Measles and Rubella Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Measles and Rubella Vaccines Industry Ranking 2023 VS 2024 VS 2025
2.5 Global Key Manufacturers of Measles and Rubella Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Measles and Rubella Vaccines, Product Type & Application
2.7 Measles and Rubella Vaccines Market Competitive Situation and Trends
2.7.1 Measles and Rubella Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Measles and Rubella Vaccines Players Market Share by Revenue
2.7.3 Global Measles and Rubella Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Measles and Rubella Vaccines Retrospective Market Scenario by Region
3.1 Global Measles and Rubella Vaccines Market Size by Region: 2020 Versus 2024 Versus 2025
3.2 Global Measles and Rubella Vaccines Global Measles and Rubella Vaccines Sales by Region: 2020-2031
3.2.1 Global Measles and Rubella Vaccines Sales by Region: 2020-2025
3.2.2 Global Measles and Rubella Vaccines Sales by Region: 2026-2031
3.3 Global Measles and Rubella Vaccines Global Measles and Rubella Vaccines Revenue by Region: 2020-2031
3.3.1 Global Measles and Rubella Vaccines Revenue by Region: 2020-2025
3.3.2 Global Measles and Rubella Vaccines Revenue by Region: 2026-2031
3.4 North America Measles and Rubella Vaccines Market Facts & Figures by Country
3.4.1 North America Measles and Rubella Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Measles and Rubella Vaccines Sales by Country (2020-2031)
3.4.3 North America Measles and Rubella Vaccines Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Measles and Rubella Vaccines Market Facts & Figures by Country
3.5.1 Europe Measles and Rubella Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Measles and Rubella Vaccines Sales by Country (2020-2031)
3.5.3 Europe Measles and Rubella Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Measles and Rubella Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Measles and Rubella Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Measles and Rubella Vaccines Sales by Country (2020-2031)
3.6.3 Asia Pacific Measles and Rubella Vaccines Revenue by Country (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Measles and Rubella Vaccines Market Facts & Figures by Country
3.7.1 Latin America Measles and Rubella Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Measles and Rubella Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Measles and Rubella Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Measles and Rubella Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Measles and Rubella Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Measles and Rubella Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Measles and Rubella Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Measles and Rubella Vaccines Sales by Type (2020-2031)
4.1.1 Global Measles and Rubella Vaccines Sales by Type (2020-2025)
4.1.2 Global Measles and Rubella Vaccines Sales by Type (2026-2031)
4.1.3 Global Measles and Rubella Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Measles and Rubella Vaccines Revenue by Type (2020-2031)
4.2.1 Global Measles and Rubella Vaccines Revenue by Type (2020-2025)
4.2.2 Global Measles and Rubella Vaccines Revenue by Type (2026-2031)
4.2.3 Global Measles and Rubella Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Measles and Rubella Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Measles and Rubella Vaccines Sales by Application (2020-2031)
5.1.1 Global Measles and Rubella Vaccines Sales by Application (2020-2025)
5.1.2 Global Measles and Rubella Vaccines Sales by Application (2026-2031)
5.1.3 Global Measles and Rubella Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Measles and Rubella Vaccines Revenue by Application (2020-2031)
5.2.1 Global Measles and Rubella Vaccines Revenue by Application (2020-2025)
5.2.2 Global Measles and Rubella Vaccines Revenue by Application (2026-2031)
5.2.3 Global Measles and Rubella Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Measles and Rubella Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Serum Institute of India Ltd.
6.1.1 Serum Institute of India Ltd. Corporation Information
6.1.2 Serum Institute of India Ltd. Description and Business Overview
6.1.3 Serum Institute of India Ltd. Measles and Rubella Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Serum Institute of India Ltd. Measles and Rubella Vaccines Product Portfolio
6.1.5 Serum Institute of India Ltd. Recent Developments/Updates
6.2 Merck & Co. Inc.
6.2.1 Merck & Co. Inc. Corporation Information
6.2.2 Merck & Co. Inc. Description and Business Overview
6.2.3 Merck & Co. Inc. Measles and Rubella Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck & Co. Inc. Measles and Rubella Vaccines Product Portfolio
6.2.5 Merck & Co. Inc. Recent Developments/Updates
6.3 GlaxoSmithKline Inc.
6.3.1 GlaxoSmithKline Inc. Corporation Information
6.3.2 GlaxoSmithKline Inc. Description and Business Overview
6.3.3 GlaxoSmithKline Inc. Measles and Rubella Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline Inc. Measles and Rubella Vaccines Product Portfolio
6.3.5 GlaxoSmithKline Inc. Recent Developments/Updates
6.4 Takeda Pharmaceutical Company
6.4.1 Takeda Pharmaceutical Company Corporation Information
6.4.2 Takeda Pharmaceutical Company Description and Business Overview
6.4.3 Takeda Pharmaceutical Company Measles and Rubella Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Takeda Pharmaceutical Company Measles and Rubella Vaccines Product Portfolio
6.4.5 Takeda Pharmaceutical Company Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Measles and Rubella Vaccines Industry Chain Analysis
7.2 Measles and Rubella Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Measles and Rubella Vaccines Production Mode & Process
7.4 Measles and Rubella Vaccines Sales and Marketing
7.4.1 Measles and Rubella Vaccines Sales Channels
7.4.2 Measles and Rubella Vaccines Distributors
7.5 Measles and Rubella Vaccines Customers
8 Measles and Rubella Vaccines Market Dynamics
8.1 Measles and Rubella Vaccines Industry Trends
8.2 Measles and Rubella Vaccines Market Drivers
8.3 Measles and Rubella Vaccines Market Challenges
8.4 Measles and Rubella Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Measles and Rubella Vaccines Market Value Comparison by Type (2025-2031) & (US$ Million)
Table 2. Global Measles and Rubella Vaccines Market Value Comparison by Application (2025-2031) & (US$ Million)
Table 3. Global Measles and Rubella Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Measles and Rubella Vaccines Sales (K Doses) of Key Manufacturers (2020-2025)
Table 5. Global Measles and Rubella Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Measles and Rubella Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Measles and Rubella Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Measles and Rubella Vaccines Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Measles and Rubella Vaccines, Industry Ranking, 2023 VS 2024 VS 2025
Table 10. Global Key Manufacturers of Measles and Rubella Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Measles and Rubella Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Measles and Rubella Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Measles and Rubella Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measles and Rubella Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Measles and Rubella Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Measles and Rubella Vaccines Sales by Region (2020-2025) & (K Doses)
Table 18. Global Measles and Rubella Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Measles and Rubella Vaccines Sales by Region (2026-2031) & (K Doses)
Table 20. Global Measles and Rubella Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Measles and Rubella Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Measles and Rubella Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Measles and Rubella Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Measles and Rubella Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Measles and Rubella Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Measles and Rubella Vaccines Sales by Country (2020-2025) & (K Doses)
Table 27. North America Measles and Rubella Vaccines Sales by Country (2026-2031) & (K Doses)
Table 28. North America Measles and Rubella Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Measles and Rubella Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Measles and Rubella Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Measles and Rubella Vaccines Sales by Country (2020-2025) & (K Doses)
Table 32. Europe Measles and Rubella Vaccines Sales by Country (2026-2031) & (K Doses)
Table 33. Europe Measles and Rubella Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Measles and Rubella Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Measles and Rubella Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Measles and Rubella Vaccines Sales by Region (2020-2025) & (K Doses)
Table 37. Asia Pacific Measles and Rubella Vaccines Sales by Region (2026-2031) & (K Doses)
Table 38. Asia Pacific Measles and Rubella Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Measles and Rubella Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Measles and Rubella Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Measles and Rubella Vaccines Sales by Country (2020-2025) & (K Doses)
Table 42. Latin America Measles and Rubella Vaccines Sales by Country (2026-2031) & (K Doses)
Table 43. Latin America Measles and Rubella Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Measles and Rubella Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Measles and Rubella Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East & Africa Measles and Rubella Vaccines Sales by Country (2020-2025) & (K Doses)
Table 47. Middle East & Africa Measles and Rubella Vaccines Sales by Country (2026-2031) & (K Doses)
Table 48. Middle East & Africa Measles and Rubella Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Measles and Rubella Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Measles and Rubella Vaccines Sales (K Doses) by Type (2020-2025)
Table 51. Global Measles and Rubella Vaccines Sales (K Doses) by Type (2026-2031)
Table 52. Global Measles and Rubella Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Measles and Rubella Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Measles and Rubella Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Measles and Rubella Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Measles and Rubella Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Measles and Rubella Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Measles and Rubella Vaccines Price (US$/Dose) by Type (2020-2025)
Table 59. Global Measles and Rubella Vaccines Price (US$/Dose) by Type (2026-2031)
Table 60. Global Measles and Rubella Vaccines Sales (K Doses) by Application (2020-2025)
Table 61. Global Measles and Rubella Vaccines Sales (K Doses) by Application (2026-2031)
Table 62. Global Measles and Rubella Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Measles and Rubella Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Measles and Rubella Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Measles and Rubella Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Measles and Rubella Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Measles and Rubella Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Measles and Rubella Vaccines Price (US$/Dose) by Application (2020-2025)
Table 69. Global Measles and Rubella Vaccines Price (US$/Dose) by Application (2026-2031)
Table 70. Serum Institute of India Ltd. Corporation Information
Table 71. Serum Institute of India Ltd. Description and Business Overview
Table 72. Serum Institute of India Ltd. Measles and Rubella Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. Serum Institute of India Ltd. Measles and Rubella Vaccines Product
Table 74. Serum Institute of India Ltd. Recent Developments/Updates
Table 75. Merck & Co. Inc. Corporation Information
Table 76. Merck & Co. Inc. Description and Business Overview
Table 77. Merck & Co. Inc. Measles and Rubella Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. Merck & Co. Inc. Measles and Rubella Vaccines Product
Table 79. Merck & Co. Inc. Recent Developments/Updates
Table 80. GlaxoSmithKline Inc. Corporation Information
Table 81. GlaxoSmithKline Inc. Description and Business Overview
Table 82. GlaxoSmithKline Inc. Measles and Rubella Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. GlaxoSmithKline Inc. Measles and Rubella Vaccines Product
Table 84. GlaxoSmithKline Inc. Recent Developments/Updates
Table 85. Takeda Pharmaceutical Company Corporation Information
Table 86. Takeda Pharmaceutical Company Description and Business Overview
Table 87. Takeda Pharmaceutical Company Measles and Rubella Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. Takeda Pharmaceutical Company Measles and Rubella Vaccines Product
Table 89. Takeda Pharmaceutical Company Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Measles and Rubella Vaccines Distributors List
Table 93. Measles and Rubella Vaccines Customers List
Table 94. Measles and Rubella Vaccines Market Trends
Table 95. Measles and Rubella Vaccines Market Drivers
Table 96. Measles and Rubella Vaccines Market Challenges
Table 97. Measles and Rubella Vaccines Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Measles and Rubella Vaccines
Figure 2. Global Measles and Rubella Vaccines Market Value Comparison by Type (2025-2031) & (US$ Million)
Figure 3. Global Measles and Rubella Vaccines Market Share by Type in 2024 & 2031
Figure 4. Monovalent Vaccines Product Picture
Figure 5. Multivalent Vaccines Product Picture
Figure 6. Global Measles and Rubella Vaccines Market Value Comparison by Application (2025-2031) & (US$ Million)
Figure 7. Global Measles and Rubella Vaccines Market Share by Application in 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Measles and Rubella Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Measles and Rubella Vaccines Market Size (2020-2031) & (US$ Million)
Figure 13. Global Measles and Rubella Vaccines Sales (2020-2031) & (K Doses)
Figure 14. Global Measles and Rubella Vaccines Average Price (US$/Dose) & (2020-2031)
Figure 15. Measles and Rubella Vaccines Report Years Considered
Figure 16. Measles and Rubella Vaccines Sales Share by Manufacturers in 2024
Figure 17. Global Measles and Rubella Vaccines Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest Measles and Rubella Vaccines Players: Market Share by Revenue in 2024
Figure 19. Measles and Rubella Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2020 VS 2024
Figure 20. Global Measles and Rubella Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Measles and Rubella Vaccines Sales Market Share by Country (2020-2031)
Figure 22. North America Measles and Rubella Vaccines Revenue Market Share by Country (2020-2031)
Figure 23. United States Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Measles and Rubella Vaccines Sales Market Share by Country (2020-2031)
Figure 26. Europe Measles and Rubella Vaccines Revenue Market Share by Country (2020-2031)
Figure 27. Germany Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Measles and Rubella Vaccines Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Measles and Rubella Vaccines Revenue Market Share by Region (2020-2031)
Figure 34. China Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Measles and Rubella Vaccines Sales Market Share by Country (2020-2031)
Figure 44. Latin America Measles and Rubella Vaccines Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Measles and Rubella Vaccines Sales Market Share by Country (2020-2031)
Figure 49. Middle East & Africa Measles and Rubella Vaccines Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Measles and Rubella Vaccines by Type (2020-2031)
Figure 54. Global Revenue Market Share of Measles and Rubella Vaccines by Type (2020-2031)
Figure 55. Global Measles and Rubella Vaccines Price (US$/Dose) by Type (2020-2031)
Figure 56. Global Sales Market Share of Measles and Rubella Vaccines by Application (2020-2031)
Figure 57. Global Revenue Market Share of Measles and Rubella Vaccines by Application (2020-2031)
Figure 58. Global Measles and Rubella Vaccines Price (US$/Dose) by Application (2020-2031)
Figure 59. Measles and Rubella Vaccines Value Chain
Figure 60. Measles and Rubella Vaccines Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

※参考情報

麻疹（はしか）および風疹（ふうしん）ワクチンは、これらのウイルスによって引き起こされる感染症の予防を目的としたワクチンです。麻疹は非常に感染力が強く、合併症を伴う可能性が高い病気であり、風疹も比較的軽い病気ですが、妊婦が感染した場合には胎児に深刻な影響を及ぼすことがあります。これらのワクチンは、公共の健康を守る上で極めて重要な役割を果たしています。

麻疹ワクチンは、麻疹ウイルスに対する免疫を誘導するために使用されており、通常は生ワクチンとして提供されます。生ワクチンは弱毒化されたウイルスを含んでおり、接種後に感染を模倣することで免疫系を活性化します。風疹ワクチンも生ワクチンであり、風疹ウイルスに対する免疫を形成します。麻疹と風疹のワクチンは多くの場合、同時に接種されることが多く、これを麻疹・風疹（MMR）ワクチンと呼ぶこともあります。

特徴として、麻疹および風疹ワクチンは一般に非常に効果的で、接種率が高い場合には集団免疫を形成し、地域社会全体での感染の拡大を防ぐことができます。麻疹に関しては、ワクチン接種後に約95％以上の人が免疫を獲得し、再感染のリスクが大幅に低下します。風疹についても、同様に高い効果が認められています。

接種の時期については、麻疹は1歳ごろに第一次接種を行い、通常は再接種として幼稚園や小学校へ入る前に追加接種が行われます。風疹は特に妊婦との接触が多い年齢層において接種が推奨されており、特に妊娠を希望する女性にはワクチン接種が重要です。

用途としては、麻疹と風疹ワクチンは、個人の免疫を高めるだけでなく、感染症の流行を防ぐための公衆衛生対策としても重要です。麻疹と風疹は共に予防接種によって根絶可能な病気であり、世界的にワクチン接種プログラムが実施されています。特に、世界保健機関（WHO）は、麻疹と風疹の撲滅を目指しており、各国の健康政策の中でワクチン接種が奨励されています。

関連技術としては、ワクチンの製造技術の進展が挙げられます。従来の卵培養法に加えて、細胞培養技術や遺伝子組換え技術の発展により、より安全で効果的なワクチンの開発が進められています。また、ワクチン接種の際に注射器を使用するだけでなく、経口接種や鼻腔からの投与方法も研究されています。これにより、接種の負担を軽減し、より多くの人々にワクチンを届けることが可能になると期待されています。

ワクチン接種に際しては、接種後に一時的に発熱や発疹といった副反応が見られることがありますが、これらは通常軽度であり、重篤な副反応はまれです。それでも、予防接種の重要性を啓発し、副反応に関する正しい情報を提供することは、ワクチン接種率の向上に寄与します。

また、麻疹および風疹ワクチンに関する社会的な側面も無視できません。接種への理解や関心を高めたり、ワクチンに対する誤解や偏見をなくすための教育活動が求められます。特にインターネットの普及により、誤った情報が広がりやすくなっており、正確な情報提供が重要となります。

世界中で麻疹と風疹のワクチン接種が推奨されている中、日本でも国や自治体による定期接種プログラムが実施されています。これにより、ほとんどの子供が接種を受けることができ、世代を超えた集団免疫を形成することが可能になります。特に、麻疹については、過去に流行が発生した経験を考慮すれば、ワクチン接種の重要性はますます増しています。

麻疹および風疹ワクチンは、感染症の予防において非常に重要なツールであり、その効果的な使用と広範な接種により、将来的にはこれらの病気を根絶できる可能性も秘めています。科学技術の進歩により、ワクチンはますます安全で効果的になってきており、予防接種によって得られる利益は計り知れません。これは個人の健康を守るだけでなく、広く社会全体の健康を守るためにも不可欠な取り組みです。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ウイルスワクチンのグローバル市場（～2030年）：一価ワクチン、多価ワクチン
  • はしか・おたふく風邪・風疹ウイルスワクチンの世界市場2025年：こども用、大人用
  • 世界の麻疹・おたふく風邪・風疹ウイルス生ワクチン市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7494 )"麻疹/風疹ワクチンの世界市場2025年：一価ワクチン、多価ワクチン" (英文：Global Measles and Rubella Vaccines Market Research Report 2025)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。